The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Oct 28, 2022--
The global gene expression analysis market size reached US$ 4.2 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.8 Billion by 2027, exhibiting a CAGR of 10.87% during 2021-2027.
Agilent Technologies Inc.
BGI Genomics Co. Ltd.
Bio-Rad Laboratories Inc.
Eurofins GSC Lux SARL
F. Hoffmann-La Roche Ltd
GE Healthcare
Illumina Inc.
Oxford Gene Technology IP Limited
Pacific Biosciences of California Inc.
PerkinElmer Inc.
QIAGEN GmbH
Thermo Fisher Scientific Inc.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products.
They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.
The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth.
Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.
Key Questions Answered in This Report:
How has the global gene expression analysis market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global gene expression analysis market?
What is the breakup of the market based on the products & services?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the capacity?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the market?
What is the structure of the global gene expression analysis market and who are the key players?
What is the degree of competition in the market?
5 Global Gene Expression Analysis Market
6 Market Breakup by Products & Services
7 Market Breakup by Technology
8 Market Breakup by Capacity
9 Market Breakup by End-User
10 Market Breakup by Region
13 Porters Five Forces Analysis
15.3 Profiles of Key Players
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/28/2022 04:20 AM/DISC: 10/28/2022 04:21 AM
http://www.businesswire.com/news/home/20221028005159/en